Metropolis Healthcare Limited (BOM:542650)
India · Delayed Price · Currency is INR 1,946.95
-37.55 (-1.89%)
At close: Feb 13, 2026
Metropolis Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 1,450 | 1,278 | 1,429 | 2,142 | 1,831 |
Depreciation & Amortization | 892.3 | 846.45 | 806.27 | 562.1 | 410.4 |
Other Amortization | 194.52 | 98.23 | 85.89 | 70.13 | 49.05 |
Loss (Gain) From Sale of Assets | -17.59 | - | -0.08 | 0.16 | 0.11 |
Asset Writedown & Restructuring Costs | - | - | 1.35 | 2.22 | - |
Loss (Gain) From Sale of Investments | -75.06 | -11.56 | -6.78 | -4.26 | -4.91 |
Stock-Based Compensation | 70.08 | 14.16 | 2.85 | 68.57 | 77.88 |
Provision & Write-off of Bad Debts | 97.09 | 113.52 | -21.72 | -28.48 | 217.35 |
Other Operating Activities | 173.58 | 247.21 | 103.19 | -115.54 | 62.53 |
Change in Accounts Receivable | -118.89 | -123.7 | 157.72 | 115.87 | -164.64 |
Change in Inventory | 18.75 | 58.98 | 65.15 | -79.37 | -161.48 |
Change in Accounts Payable | 48.38 | 57 | -53.12 | -165.07 | 234.42 |
Change in Other Net Operating Assets | -105.38 | 62.24 | -98.64 | -35.41 | -61.36 |
Operating Cash Flow | 2,627 | 2,641 | 2,471 | 2,533 | 2,490 |
Operating Cash Flow Growth | -0.50% | 6.87% | -2.44% | 1.70% | 15.83% |
Capital Expenditures | -434.1 | -637.61 | -526.34 | -306.63 | -282.73 |
Sale of Property, Plant & Equipment | 20 | - | 1.49 | - | 0.86 |
Cash Acquisitions | -1,312 | -6.5 | -4.51 | -6,379 | -53.95 |
Sale (Purchase) of Intangibles | -252.02 | - | - | - | - |
Investment in Securities | -48.32 | -271.66 | 932.29 | -800.44 | 848.52 |
Other Investing Activities | 15.77 | 21.65 | 65.01 | 110.62 | 104.3 |
Investing Cash Flow | -2,011 | -894.12 | 467.94 | -7,376 | 617.01 |
Long-Term Debt Issued | - | - | - | 6,000 | - |
Total Debt Issued | - | - | - | 6,000 | - |
Long-Term Debt Repaid | -680.87 | -1,382 | -2,242 | -3,791 | -179.83 |
Total Debt Repaid | -680.87 | -1,382 | -2,242 | -3,791 | -179.83 |
Net Debt Issued (Repaid) | -680.87 | -1,382 | -2,242 | 2,209 | -179.83 |
Issuance of Common Stock | 0.1 | 0.03 | 1.84 | 19.75 | 343.18 |
Common Dividends Paid | - | -204.96 | -409.69 | -409.38 | -408.93 |
Other Financing Activities | -185.57 | -224.8 | -273.24 | -194.48 | -81.32 |
Financing Cash Flow | -866.34 | -1,812 | -2,923 | 1,625 | -326.9 |
Foreign Exchange Rate Adjustments | 9.8 | 3.25 | 12.97 | -13.64 | 13.8 |
Miscellaneous Cash Flow Adjustments | 8.21 | -0 | - | 25.29 | - |
Net Cash Flow | -231.43 | -62.15 | 28.53 | -3,206 | 2,794 |
Free Cash Flow | 2,193 | 2,003 | 1,945 | 2,226 | 2,208 |
Free Cash Flow Growth | 9.50% | 3.01% | -12.65% | 0.84% | 23.47% |
Free Cash Flow Margin | 16.48% | 16.59% | 16.94% | 18.12% | 22.12% |
Free Cash Flow Per Share | 42.60 | 38.98 | 37.85 | 43.30 | 43.15 |
Cash Interest Paid | 185.57 | 224.8 | 273.24 | 183.84 | 73.08 |
Cash Income Tax Paid | 439.75 | 373.84 | 515.8 | 825.12 | 568.32 |
Levered Free Cash Flow | 1,560 | 1,840 | 1,280 | 1,723 | 1,971 |
Unlevered Free Cash Flow | 1,676 | 1,981 | 1,448 | 1,846 | 2,020 |
Change in Working Capital | -157.13 | 54.52 | 71.11 | -163.98 | -153.07 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.